Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,490 | -36,917 | -26,603 | -17,989 | -8,774 |
| Depreciation Amortization | 230 | 892 | 647 | 421 | 226 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1,753 |
| Other Working Capital | -7,329 | 439 | 457 | 4,463 | 4,540 |
| Other Operating Activity | 4,019 | 3,105 | 3,503 | 1,442 | -1,260 |
| Operating Cash Flow | $-17,570 | $-32,481 | $-21,996 | $-11,663 | $-3,515 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,010 | -2,211 | -2,666 | -1,372 | -236 |
| Investing Cash Flow | $-2,010 | $-2,211 | $-2,666 | $-1,372 | $-236 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,594 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 44,516 | 44,516 | 44,485 | 44,631 |
| Other Financing Activity | 0 | -500 | 0 | 0 | 0 |
| Financing Cash Flow | $29,594 | $44,016 | $44,516 | $44,485 | $44,631 |
| Beginning Cash Position | 20,812 | 11,488 | 11,488 | 11,488 | 11,488 |
| End Cash Position | 30,826 | 20,812 | 31,342 | 42,938 | 52,368 |
| Net Cash Flow | $10,014 | $9,324 | $19,854 | $31,450 | $40,880 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,570 | -32,481 | -21,996 | -11,663 | -3,515 |
| Capital Expenditure | -2,010 | -2,211 | -2,666 | -1,372 | -236 |
| Free Cash Flow | -19,580 | -34,692 | -24,662 | -13,035 | -3,751 |